comparemela.com

Latest Breaking News On - Codagenix - Page 1 : comparemela.com

Codagenix Announces Appointment of Paul Grint, MD, as Executive Chairman of its Board of Directors

/PRNewswire/ Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology.

United statesSan diegoCity ofUnited kingdomPersephone biosciencesIgnacio guerrero rosCardea bioJ robert colemanAmpliphi biosciencesLeo vartorellaEckard wimmerPaul grintUniversity of californiaNational academy of scienceBartholomew hospital medical collegeMedicine at forest research institute

Codagenix Announces Award with the US Department of Defense for Development of Balanced, Tetravalent Dengue Vaccine

/PRNewswire/ Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology.

United statesJ robert colemanDepartment of agricultureDepartment of defenseWarfighter medical research programHealth affairsPrnewswire codagenix incUs army medical research acquisition activityOffice of theJoint warfighter medical research programInvestigational new drugLatin americanChief executive officerMedical research acquisition activityFort detrickAssistant secretary

Codagenix Completes Dosing in Phase 1 Trial of Universal Influenza Vaccine

/PRNewswire/ Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology.

J robert colemanPrnewswire codagenix incChief executive officer

Codagenix Initiates Phase 1 Evaluation of Intranasal Vaccine CoviLiv™ for Use as COVID-19 Booster

/PRNewswire/ Codagenix Inc., a clinical-stage synthetic biology company with a rational vaccine design platform aimed at infectious diseases and cancer, in.

City ofUnited kingdomJ robert colemanPrnewswire codagenix incSerum institute of india pvtWorld health organizationSerum instituteSerum institute of indiaChief executive officerSolidarity trial vaccines

Codagenix Welcomes Bruce Taillon as Executive Vice President of Animal Health

/PRNewswire/ Codagenix, Inc., a clinical-stage synthetic biology company pioneering a novel platform for vaccines and oncolytic virus therapies, today.

Brucee taillonJ robert colemanCarnegie mellon universityAnimal health at codagenixBusiness product developmentEnzo life sciencesInnovation business development of elanco animal healthHuman development at washington universityPrnewswire codagenix incHealthcare business developmentUniversity of south carolinaLife sciencesAnimal healthNational institute of child healthUnited states department of agricultureExecutive vice president

vimarsana © 2020. All Rights Reserved.